Zobrazeno 1 - 10
of 195
pro vyhledávání: ''
Autor:
Liesbeth C. de Wreede, Jürgen Finke, Diderik Jan Eikema, Jorge Sierra, Yves Beguin, Gérard Socié, Achilles Anagnostopoulos, Zübeyde Nur Özkurt, Anja van Biezen, Tobias Gedde-Dahl, Guido Kobbe, Maija Itälä-Remes, Dietger Niederwieser, Linda Koster, Marie Robin, Theo de Witte, Pavel Jindra, Johan Maertens, Dimitris Ziagkos, Eline M. P. Cremers, Nicolaus Kröger, Dietrich W. Beelen, Arnon Nagler, Per Ljungman
Publikováno v:
Cremers, E M P, de Witte, T, de Wreede, L, Eikema, D-J, Koster, L, van Biezen, A, Finke, J R, Socié, G, Beelen, D, Maertens, J, Nagler, A, Kobbe, G, Ziagkos, D, Itälä-Remes, M, Gedde-Dahl, T, Sierra, J, Niederwieser, D, Ljungman, P, Beguin, Y, Ozkurt, Z N, Anagnostopoulos, A, Jindra, P, Robin, M & Kröger, N 2019, ' A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation * ', Leukemia and Lymphoma, vol. 60, no. 10, pp. 2404-2414 . https://doi.org/10.1080/10428194.2019.1594215
LEUKEMIA & LYMPHOMA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Leukemia & Lymphoma, 60, 2404-2414
Leukemia & Lymphoma, 60, 10, pp. 2404-2414
Leukemia & Lymphoma, 60(10), 2404-2414
Leukemia and Lymphoma, 60(10), 2404-2414. Informa Healthcare
LEUKEMIA & LYMPHOMA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Leukemia & Lymphoma, 60, 2404-2414
Leukemia & Lymphoma, 60, 10, pp. 2404-2414
Leukemia & Lymphoma, 60(10), 2404-2414
Leukemia and Lymphoma, 60(10), 2404-2414. Informa Healthcare
Most myelodysplastic syndromes (MDS)-patients receive multiple red blood cell transfusions (RBCT). Transfusions may cause iron-related toxicity and mortality, influencing outcome after allogeneic HSCT. This prospective non-interventional study evalua
Autor:
Raija Silvennoinen, Ville Varmavuo, Jukka Pelkonen, Jaakko Valtola, Pentti Mäntymaa, Antti Ropponen, Marjaana Säily, Timo Siitonen, Esa Jantunen, Mervi Putkonen, Marja Pyörälä, Marja Sankelo, Eeva-Riitta Savolainen, Anu Partanen
Publikováno v:
Leukemialymphoma. 60(2)
The composition of autologous blood grafts after cryopreservation, post-transplant hematological recovery up to 1 year and immune recovery up to 6 months as well as outcome was analyzed in 87 patients with multiple myeloma (MM). The patients receivin
Autor:
Jörg Westermann, Renate Arnold, Jana Ihlow, Seval Türkmen, Annabel Sick, Sophia Gross, Bernd Dörken, Tanja Schneider, Anne Flörcken, Thomas Burmeister
Publikováno v:
Leukemialymphoma. 60(1)
Increased serum ferritin (SF) is common in hematologic malignancies; however, its prognostic role in acute myeloid leukemia (AML) is not clearly established. We examined the impact of baseline SF on long-term survival in 137 intensively treated AML p
Autor:
Leland Metheny, Bernadette McQuigg, Richard J. Creger, Ehsan Malek, Fahrettin Covut, Paolo Caimi, Merle Kolk, Anand Tandra, Ben K. Tomlinson, Folashade Otegbeye, Lauren Brister, Hillard M. Lazarus, Brenda W. Cooper, Marcos de Lima
Publikováno v:
Leukemialymphoma. 59(7)
Anti-thymocyte globulin (ATG) is often added to hematopoietic stem cell transplant conditioning regimens to prevent graft rejection and reduce graft-versus-host disease (GVHD). Doses used in retrospective and prospective clinical trials have ranged f
Publikováno v:
Leukemialymphoma. 59(6)
To assess the relevance of C-X-C chemokine receptor type 4 (CXCR4) and mammalian target of rapamycin (mTOR) to large-B-cell lymphoma (DLBCL), levels of protein expression were measured in 56 DLBCL patients who had received rituximab-based therapy. Of
Autor:
Lee Ratner, Jeannette Y. Lee, Richard F. Ambinder, Malek Faham, Sylvia Silver, Shelly Lensing, David H. Henry, Nina D. Wagner-Johnston, Ariela Noy
Publikováno v:
Leukemialymphoma. 58(12)
Patients with HIV are at increased risk for developing B-cell lymphomas likely due in part to chronic antigen stimulation leading to clonal immunoglobulin (Ig) gene rearrangements. Clonal Ig DNA has been identified in the plasma in patients with lymp
Autor:
Sergey Gorlatov, Ana Garrido, Kanti R. Rai, Rajendra N. Damle, Carol Moreno, Rosa Bosch, Miquel Granell, Albert Esquirol, Silvana Saavedra, Jorge Sierra, Irene Garcia, Emili Montserrat, Eva Puy Vicente, Julio Delgado, Nicholas Chiorazzi, Laura Blanco, Marta Pratcorona, Josep F. Nomdedeu, Rodrigo Martino, Alba Mora, Sonia Jansa, Gerardo Ferrer
Publikováno v:
Leukemialymphoma. 58(11)
In normal B-cells, B-cell antigen receptor (BCR) signaling can be negatively regulated by the low-affinity receptor FcγRIIb (CD32b). To better understand the role of FcγRIIb in chronic lymphocytic leukemia (CLL), we correlated its expression on 155
Publikováno v:
Leukemialymphoma. 58(11)
Molecular testing has aided the diagnosis of the myeloproliferative neoplasms (MPNs), which may still be obfuscated by inaccurate clinical diagnostic criteria [1]. Whereas the great majority of pol...
Publikováno v:
Leukemialymphoma. 58(6)
Chronic lymphocytic leukemia (CLL) is a neoplastic disorder of mature B lymphocytes. While traditionally treated with combinations of chemoimmunotherapy, the therapeutic options for CLL have expanded in recent years with the emergence of novel oral a
Autor:
Sanjay R. Mohan, Amma Bosompem, Yan Guo, Shilin Zhao, Annette S. Kim, Quanhu Sheng, Shaoying Li, Kasey C. Vickers, Stephen A. Strickland
Publikováno v:
Leukemialymphoma. 58(9)
Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders of the elderly that carry an increased risk of progression to acute myeloid leukemia (AML). Since small non-coding RNAs (sRNAs), including microRNA (miRNAs), act as regulators of cell